Loading…

Treatment of turkeys with nitroimidazoles: Impact of the selection of target analytes and matrices on an effective residue control

In several animal studies turkeys were treated with different nitroimidazoles (Dimetridazole, Metronidazole, Ronidazole, Ipronidazole). After slaughtering, different matrices (breast muscle, leg muscle, liver, plasma, retina) were analysed for their analyte content, for the percentage of hydroxy-met...

Full description

Saved in:
Bibliographic Details
Published in:Analytica chimica acta 2004-09, Vol.521 (2), p.189-200
Main Authors: Polzer, J, Stachel, C, Gowik, P
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 200
container_issue 2
container_start_page 189
container_title Analytica chimica acta
container_volume 521
creator Polzer, J
Stachel, C
Gowik, P
description In several animal studies turkeys were treated with different nitroimidazoles (Dimetridazole, Metronidazole, Ronidazole, Ipronidazole). After slaughtering, different matrices (breast muscle, leg muscle, liver, plasma, retina) were analysed for their analyte content, for the percentage of hydroxy-metabolites, for homogeneity, stability and bound, and conjugated residues. The tests showed that for animals treated with Dimetridazole and Ipronidazole, the hydroxy-metabolites (2-hydroxymethyl-1-methyl-5-nitroimidazole (HMMNI) and 1-methyl-2-(2′-hydroxyisopropyl)-5-nitroimidazole (IPZOH)) are the relevant target analytes, whereas for animals treated with Ronidazole and Metronidazole, the parent drug itself is the most relevant analyte. In muscle samples an inhomogeneous analyte distribution was found. Degradation studies showed a rapid decline of the analyte concentration in muscle and liver samples stored at room temperature and a decelerated degradation at 4 °C. In plasma and retina samples, however, the analytes were stable during storage under the same conditions. In these matrices the analytes were found to be present in considerably higher concentrations than in muscle or liver and could be detected for a longer period of time after withdrawal of the medication. Therefore, plasma or retina can be recommended as target matrices for the residue control of nitroimidazoles in turkeys.
doi_str_mv 10.1016/j.aca.2004.06.019
format article
fullrecord <record><control><sourceid>elsevier_pasca</sourceid><recordid>TN_cdi_pascalfrancis_primary_16031741</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0003267004007147</els_id><sourcerecordid>S0003267004007147</sourcerecordid><originalsourceid>FETCH-LOGICAL-e235t-da720ba895a8039000a424223b2d8959d4928ce71adb684da191c1979c3122f13</originalsourceid><addsrcrecordid>eNotkElPAzEMhSMEEqXwA7jlwnGGbJ0FTgixVKrEpZwjN_HQlFmqJC0qR345GcrJ9tMn2-8Rcs1Zzhkvbjc5GMgFYypnRc54fUImvCplpqRQp2TCGJOZKEp2Ti5C2KRRcKYm5GfpEWKHfaRDQ-POf-Ih0C8X17R30Q-ucxa-hxbDHZ13WzBHbo00YIsmuqH_E8B_YKTQQ3uIGFJjaQfRO5OGhEBPsWlGfo_UY3B2h9QMfbrQXpKzBtqAV_91St6fn5aPr9ni7WX--LDIUMhZzCyUgq2gqmdQMVknB6CEEkKuhE1ibVUtKoMlB7sqKmWB19zwuqyN5EI0XE7JzXHvFoKBtvHQGxf01rsO_EHzgkleqpG7P3KYntk79DoYh71B63xyoO3gNGd6jF1vdIpdj7FrVugUu_wF6Al4zg</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Treatment of turkeys with nitroimidazoles: Impact of the selection of target analytes and matrices on an effective residue control</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Polzer, J ; Stachel, C ; Gowik, P</creator><creatorcontrib>Polzer, J ; Stachel, C ; Gowik, P</creatorcontrib><description>In several animal studies turkeys were treated with different nitroimidazoles (Dimetridazole, Metronidazole, Ronidazole, Ipronidazole). After slaughtering, different matrices (breast muscle, leg muscle, liver, plasma, retina) were analysed for their analyte content, for the percentage of hydroxy-metabolites, for homogeneity, stability and bound, and conjugated residues. The tests showed that for animals treated with Dimetridazole and Ipronidazole, the hydroxy-metabolites (2-hydroxymethyl-1-methyl-5-nitroimidazole (HMMNI) and 1-methyl-2-(2′-hydroxyisopropyl)-5-nitroimidazole (IPZOH)) are the relevant target analytes, whereas for animals treated with Ronidazole and Metronidazole, the parent drug itself is the most relevant analyte. In muscle samples an inhomogeneous analyte distribution was found. Degradation studies showed a rapid decline of the analyte concentration in muscle and liver samples stored at room temperature and a decelerated degradation at 4 °C. In plasma and retina samples, however, the analytes were stable during storage under the same conditions. In these matrices the analytes were found to be present in considerably higher concentrations than in muscle or liver and could be detected for a longer period of time after withdrawal of the medication. Therefore, plasma or retina can be recommended as target matrices for the residue control of nitroimidazoles in turkeys.</description><identifier>ISSN: 0003-2670</identifier><identifier>EISSN: 1873-4324</identifier><identifier>DOI: 10.1016/j.aca.2004.06.019</identifier><identifier>CODEN: ACACAM</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Analytical chemistry ; Chemistry ; Chromatographic methods and physical methods associated with chromatography ; Exact sciences and technology ; Gas chromatographic methods ; Homogeneity ; Nitroimidazoles ; Plasma ; Residue control ; Retina ; Spectrometric and optical methods ; Stability ; Turkey</subject><ispartof>Analytica chimica acta, 2004-09, Vol.521 (2), p.189-200</ispartof><rights>2004 Elsevier B.V.</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16031741$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>Polzer, J</creatorcontrib><creatorcontrib>Stachel, C</creatorcontrib><creatorcontrib>Gowik, P</creatorcontrib><title>Treatment of turkeys with nitroimidazoles: Impact of the selection of target analytes and matrices on an effective residue control</title><title>Analytica chimica acta</title><description>In several animal studies turkeys were treated with different nitroimidazoles (Dimetridazole, Metronidazole, Ronidazole, Ipronidazole). After slaughtering, different matrices (breast muscle, leg muscle, liver, plasma, retina) were analysed for their analyte content, for the percentage of hydroxy-metabolites, for homogeneity, stability and bound, and conjugated residues. The tests showed that for animals treated with Dimetridazole and Ipronidazole, the hydroxy-metabolites (2-hydroxymethyl-1-methyl-5-nitroimidazole (HMMNI) and 1-methyl-2-(2′-hydroxyisopropyl)-5-nitroimidazole (IPZOH)) are the relevant target analytes, whereas for animals treated with Ronidazole and Metronidazole, the parent drug itself is the most relevant analyte. In muscle samples an inhomogeneous analyte distribution was found. Degradation studies showed a rapid decline of the analyte concentration in muscle and liver samples stored at room temperature and a decelerated degradation at 4 °C. In plasma and retina samples, however, the analytes were stable during storage under the same conditions. In these matrices the analytes were found to be present in considerably higher concentrations than in muscle or liver and could be detected for a longer period of time after withdrawal of the medication. Therefore, plasma or retina can be recommended as target matrices for the residue control of nitroimidazoles in turkeys.</description><subject>Analytical chemistry</subject><subject>Chemistry</subject><subject>Chromatographic methods and physical methods associated with chromatography</subject><subject>Exact sciences and technology</subject><subject>Gas chromatographic methods</subject><subject>Homogeneity</subject><subject>Nitroimidazoles</subject><subject>Plasma</subject><subject>Residue control</subject><subject>Retina</subject><subject>Spectrometric and optical methods</subject><subject>Stability</subject><subject>Turkey</subject><issn>0003-2670</issn><issn>1873-4324</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNotkElPAzEMhSMEEqXwA7jlwnGGbJ0FTgixVKrEpZwjN_HQlFmqJC0qR345GcrJ9tMn2-8Rcs1Zzhkvbjc5GMgFYypnRc54fUImvCplpqRQp2TCGJOZKEp2Ti5C2KRRcKYm5GfpEWKHfaRDQ-POf-Ih0C8X17R30Q-ucxa-hxbDHZ13WzBHbo00YIsmuqH_E8B_YKTQQ3uIGFJjaQfRO5OGhEBPsWlGfo_UY3B2h9QMfbrQXpKzBtqAV_91St6fn5aPr9ni7WX--LDIUMhZzCyUgq2gqmdQMVknB6CEEkKuhE1ibVUtKoMlB7sqKmWB19zwuqyN5EI0XE7JzXHvFoKBtvHQGxf01rsO_EHzgkleqpG7P3KYntk79DoYh71B63xyoO3gNGd6jF1vdIpdj7FrVugUu_wF6Al4zg</recordid><startdate>20040913</startdate><enddate>20040913</enddate><creator>Polzer, J</creator><creator>Stachel, C</creator><creator>Gowik, P</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope></search><sort><creationdate>20040913</creationdate><title>Treatment of turkeys with nitroimidazoles: Impact of the selection of target analytes and matrices on an effective residue control</title><author>Polzer, J ; Stachel, C ; Gowik, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-e235t-da720ba895a8039000a424223b2d8959d4928ce71adb684da191c1979c3122f13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Analytical chemistry</topic><topic>Chemistry</topic><topic>Chromatographic methods and physical methods associated with chromatography</topic><topic>Exact sciences and technology</topic><topic>Gas chromatographic methods</topic><topic>Homogeneity</topic><topic>Nitroimidazoles</topic><topic>Plasma</topic><topic>Residue control</topic><topic>Retina</topic><topic>Spectrometric and optical methods</topic><topic>Stability</topic><topic>Turkey</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Polzer, J</creatorcontrib><creatorcontrib>Stachel, C</creatorcontrib><creatorcontrib>Gowik, P</creatorcontrib><collection>Pascal-Francis</collection><jtitle>Analytica chimica acta</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Polzer, J</au><au>Stachel, C</au><au>Gowik, P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment of turkeys with nitroimidazoles: Impact of the selection of target analytes and matrices on an effective residue control</atitle><jtitle>Analytica chimica acta</jtitle><date>2004-09-13</date><risdate>2004</risdate><volume>521</volume><issue>2</issue><spage>189</spage><epage>200</epage><pages>189-200</pages><issn>0003-2670</issn><eissn>1873-4324</eissn><coden>ACACAM</coden><abstract>In several animal studies turkeys were treated with different nitroimidazoles (Dimetridazole, Metronidazole, Ronidazole, Ipronidazole). After slaughtering, different matrices (breast muscle, leg muscle, liver, plasma, retina) were analysed for their analyte content, for the percentage of hydroxy-metabolites, for homogeneity, stability and bound, and conjugated residues. The tests showed that for animals treated with Dimetridazole and Ipronidazole, the hydroxy-metabolites (2-hydroxymethyl-1-methyl-5-nitroimidazole (HMMNI) and 1-methyl-2-(2′-hydroxyisopropyl)-5-nitroimidazole (IPZOH)) are the relevant target analytes, whereas for animals treated with Ronidazole and Metronidazole, the parent drug itself is the most relevant analyte. In muscle samples an inhomogeneous analyte distribution was found. Degradation studies showed a rapid decline of the analyte concentration in muscle and liver samples stored at room temperature and a decelerated degradation at 4 °C. In plasma and retina samples, however, the analytes were stable during storage under the same conditions. In these matrices the analytes were found to be present in considerably higher concentrations than in muscle or liver and could be detected for a longer period of time after withdrawal of the medication. Therefore, plasma or retina can be recommended as target matrices for the residue control of nitroimidazoles in turkeys.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><doi>10.1016/j.aca.2004.06.019</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0003-2670
ispartof Analytica chimica acta, 2004-09, Vol.521 (2), p.189-200
issn 0003-2670
1873-4324
language eng
recordid cdi_pascalfrancis_primary_16031741
source ScienceDirect Freedom Collection 2022-2024
subjects Analytical chemistry
Chemistry
Chromatographic methods and physical methods associated with chromatography
Exact sciences and technology
Gas chromatographic methods
Homogeneity
Nitroimidazoles
Plasma
Residue control
Retina
Spectrometric and optical methods
Stability
Turkey
title Treatment of turkeys with nitroimidazoles: Impact of the selection of target analytes and matrices on an effective residue control
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T15%3A26%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20of%20turkeys%20with%20nitroimidazoles:%20Impact%20of%20the%20selection%20of%20target%20analytes%20and%20matrices%20on%20an%20effective%20residue%20control&rft.jtitle=Analytica%20chimica%20acta&rft.au=Polzer,%20J&rft.date=2004-09-13&rft.volume=521&rft.issue=2&rft.spage=189&rft.epage=200&rft.pages=189-200&rft.issn=0003-2670&rft.eissn=1873-4324&rft.coden=ACACAM&rft_id=info:doi/10.1016/j.aca.2004.06.019&rft_dat=%3Celsevier_pasca%3ES0003267004007147%3C/elsevier_pasca%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-e235t-da720ba895a8039000a424223b2d8959d4928ce71adb684da191c1979c3122f13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true